levamisole has been researched along with Scleroderma, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rosenthal, M | 1 |
| Choutet, P; Lorette, G; Renoux, M | 1 |
1 review(s) available for levamisole and Scleroderma, Systemic
| Article | Year |
|---|---|
A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.
Topics: Adult; Animals; Arthritis; Arthritis, Juvenile; Arthritis, Reactive; Clinical Trials as Topic; Collagen Diseases; Dermatomyositis; Double-Blind Method; Humans; Joint Diseases; Levamisole; Lupus Erythematosus, Systemic; Mice; Placebos; Psoriasis; Scleroderma, Systemic; Sjogren's Syndrome; Spondylitis, Ankylosing | 1978 |
1 trial(s) available for levamisole and Scleroderma, Systemic
| Article | Year |
|---|---|
A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.
Topics: Adult; Animals; Arthritis; Arthritis, Juvenile; Arthritis, Reactive; Clinical Trials as Topic; Collagen Diseases; Dermatomyositis; Double-Blind Method; Humans; Joint Diseases; Levamisole; Lupus Erythematosus, Systemic; Mice; Placebos; Psoriasis; Scleroderma, Systemic; Sjogren's Syndrome; Spondylitis, Ankylosing | 1978 |
1 other study(ies) available for levamisole and Scleroderma, Systemic
| Article | Year |
|---|---|
[HL-A B27 systemic scleroderma. Levamisole treatment and agranulocytosis].
Topics: Agranulocytosis; Female; HLA Antigens; Humans; Levamisole; Middle Aged; Scleroderma, Systemic | 1979 |